Weekly round-up #46

Spinning Globe

Weekly round-up #46 

 

It has been a busy week for the VALIDATE Network, so first we would like to welcome some new members:

 

New InvestigatorsDr Monde Muyoyeta (CIDRZ, Zambia), Dr Hyejon Lee (International Tuberculosis Research Centre, South Korea); Professor Vijay Prajapati (Central University of Rajasthan, India)

 

New AssociatesDr Rajiv Kumar (Banaras Hindu University, India); Dr Yiltawe Wungak (National Veterinary Research Institute, Nigeria); Dr Kushboo Borah (University of Surrey, UK)

 

New Affiliates: Shintouo Cabirou (University of Buea, Cameroon); Daniel Tapia (University of Texas Medical Branch, USA); Yemisi Obafemi (Covenant University, Nigeria); Olugbenga Taiwo (Covenant University, Nigeria); Dr Erni Nelwan (Universitas Indonesia, Indonesia); Van Le Hong (OU Clinical Research Unit, Vietnam); Emmaculate Ntang (University of Buea, Cameroon); Hannatu Abubakar Sani (Kebbi State University of Science and Technology), Patpong Rongkard (Mahidol-Oxford Tropical Medicine Research Unit, Thailand and University of Oxford, UK)

 

You can read all about their research interests in our members' directory.

 

In other news this week:

 

Our Network Manager Samantha Vermaak attended the 9th EDCTP Forum last week, where she gave a talk in the Vaccines for Neglected Diseases session about the VALIDATE Network and our connected approach to expediting vaccine R&D for tuberculosis, leishmaniasis, leprosy and melioidosis. There were many interesting speakers and talks at the Forum, as well as the official launch of the TB Vaccine Development Pathway website developed by TBVI, Aeras and other stakeholders. This will be a very useful tool for our community, so do take a look at the website.

 

We also joined our sister network IMPRINT's 2nd Annual Meeting in Kingston upon Thames, UK on Tuesday 25 September where Sam gave another presentation outlining VALIDATE's remit, aims and the benefits of VALIDATE membership.

 

Funding: 

In addition, the call for our Training Grants is still open (closing 29 October) - VALIDATE training grants offer up to £3000 to help VALIDATE Associates take advantage of training opportunities that will contribute to their professional development. This can include (but is not limited to) attendance at courses or workshops, laboratory exchange, work shadowing, and attendance at an international conference to present a talk. Find out more about these grants here.

Don't forget that all relevant external funding opportunities are listed on our website

 

Training Opportunities:

Lots of other training ideas for members are listed on our training opportunities page

 

 

Events

Make sure you register to attend the VALIDATE 2nd Annual Meeting being held on 6-7 November 2018 in York - registration closes on 1 October!

 

Job Opportunities

 

Publications:

Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making. by VALIDATE members Sophie RhodesHelen Fletcher, Thomas Evans, Richard White and collaborators in NPJ Vaccines

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A by VALIDATE members Anne WajjaBeatrice NassangaSamantha VermaakIman SattiStephen CoseHelen McShaneAlison M. Elliott in Wellcome Open Research

Let us know if you have a paper published so that we can tell all our members about it.

 

 

 

 

On twitter this week: The new WHO Global TB Report is out, showing that TB is still the world's deadliest infectious disease; AERAS highlighted their two key asks for the UNHLMTB; the 2018 Annual Conference of the NTD NGO Network is being held in Addis Ababa, Ethiopia 24-26 Sep; watch Professor Heidi Larson give her lecture entitled: "Enlightenment upside down?: The science of risk and rumour in global health" at LSHTM; read the meeting report on the 5th Global Forum on TB vaccines in Tuberculosis journal by VALIDATE members Rachel Tanner and Hazel Dockrell; and the StopTB Partnership, Johnson & Johnson, UN Foundation, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Economic Forum co-hosted a TB Innovation Summit in NYC on 23 Sept.

Follow us on Twitter @NetworkVALIDATE to keep up to date.

 

Finally, our thoughts are with all of those (including VALIDATE Co-Director Helen Fletcher) attending today’s UN General Assembly first ever High Level Meeting on TB. We hope that the meeting will lead to the much needed higher prioritisation of TB research and treatment by Heads of State and funding institutions around the world. 1.7m people still die of TB every year – this is unacceptable and needs to change.

 

 

Published: 26 September 2018